Tag: Onshoring

  • Drug Duty Nears

    With the 100 percent tariff on patented pharmaceuticals set to bite on September 29, importers race the clock while drugmakers weigh onshoring deals and pricing concessions WASHINGTON, September 8, 2026. Three weeks from today, the United States will begin collecting a 100 percent tariff on imported patented pharmaceuticals and their active ingredients from most of…

  • Drug Duty Cliff

    Three weeks before the September 29 deadline, 100 percent tariffs on patented drug imports loom for every company without an onshoring deal, and three of the industry’s biggest names are still exposed WASHINGTON, September 7, 2026 The pharmaceutical industry has entered the final three-week countdown to the broadest drug tariff in American history. On September…

  • Pharma Duty Day

    America’s 100 percent tariff on patented drug imports is now live for the industry’s biggest importers, and the first full business week under the new regime is testing supply chains, pricing models and Washington’s onshoring bet all at once. WASHINGTON, Aug. 3, 2026 – The most aggressive pharmaceutical trade action in modern American history is…

  • Pharma Cliff

    Six days before 100 percent tariffs hit patented medicines, three of the world’s biggest drugmakers still have no onshoring deal, generic makers have a new 200 percent deadline of their own, and the US drug supply chain is bracing for the most expensive week in its history WASHINGTON, July 25, 2026 The most consequential tariff…